Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

University of Illinois Chicago
Search
University of Illinois Chicago

Office of Continuing Education and Meeting Services

College of Pharmacy - Chicago | Rockford

UI Health is UIC’s academic health enterprise

Real World Use of Belatacept

Posted on October 15, 2021
Adele Rike Shields, PharmD

Author:
Adele Rike Shields, PharmD
Research Associate Professor of Surgery
University of Cincinnati
Transplant Clinical Pharmacist
The Christ Hospital

 

 

 

 

 

 

 

 

 

Disclosure(s):
Dr. Shields is co-investigator on a study funded by Bristol Myers Squibb. All of the other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose. Dr. Muran is a consultant for Veloxis.

Type of Activity: Knowledge

Learning Objectives:

  • Recognize the evolving role of belatacept in transplant immunosuppressive regimens.
  • Discuss how to manage a transplant immunosuppression regimen incorporating the use of belatacept without a calcineurin inhibitor (CNI) or long-term steroids or with alternative induction.
  • Review clinical situations in which rejection or viral infections may behave differently under belatacept.
Target Audience: Pharmacists Fee: $10 or $35 for all five courses. For ITPA 2021 participants who registered for the live program, please use the access code provided to you by email.
Release Date: October 15, 2021 Expiration Date: October 11, 2023
Estimated Time to Complete: 1.0 hour CE: 1.0 contact hours (0.01 CEUs)

Go to activity

acpe
Continuing Education Statement: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The non-accredited joint provider for this activity is Illinois Transplant Pharmacists Association. This activity has been assigned ACPE Universal Activity Number 0016-9999-21-077-H01-P, for 1.0 contact hours (0.1 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

How to Earn Credit:
Participants must complete the activity as described in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on ‘Finish Attempt’, then click on ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information please call the Office of Continuing Education and Meeting Services toll-free at (866) PHARM-CE (866-742-7623) or send an e-mail to: pharmce@uic.edu. Copyright © 2021– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on December 13, 2021